Pfizer filed suit against an Indian pharmaceutical company on Friday over its application to market generic versions of Xeljanz XR.
Xeljanz XR is an extended …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.